Connect with us

Cannabis Company Partners with Harvard University

Published

on

[dropcap class=”kp-dropcap”]O[/dropcap]n May 28, Atlas Biotechnologies Inc., and its subsidiary Atlas Growers Ltd. announced a research partnership with Harvard Global Health Catalyst (HGHC) at Harvard University. According to a press release, the new International Phytomedicines and Medical Cannabis Institute at Harvard (Harvard IPI) will delve into the efficacy of medical cannabis for medical purposes.

The research agreements will span over the next three years. Atlas will help develop phytomedicine products for pain and neurological conditions, provide input and guidance into research and collaborate on expanding education on the benefits of cannabis-based phytomedicines, among other tasks. The company plans to develop a broad range of unique cannabis cultivars, which will be used for extractions for medical research purposes.

“Atlas was founded in 2015 with the vision of improving lives by focusing on medical applications for cannabis, and advancing knowledge of its largely unexplored properties, through targeted clinical trials and research collaborations,” Atlas President & CEO Sheldon Croome stated. “We are proud to have been selected as a partner of the IPI at Harvard Medical School, arguably the world’s most prestigious and progressive medical research institution. We look forward to building a long-term relationship with Harvard Medical School, with the aim of improving lives by discovering new properties of cannabis for targeted medical applications.”

One of HGHC’s flagship initiatives is the launch of a cloud-based cancer center, which is powered by artificial intelligence and faculty from Harvard University, University of Heidelberg, Oxford University and other industry partners.

Atlas is based in Edmonton, Alberta, Canada, and Atlas Growers Ltd., is federally licensed for the cultivation and production of cannabis products, focusing on medical uses. Atlas Growers currently operates a 38,000 square foot laboratory where there are plans to produce 5,500 kg of dried cannabis annually. Current short-term plans include expanding its extraction operations to a 200,000kg per year capacity.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *